Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 2 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
Page 1
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies.
Proc Natl Acad Sci U S A. 2022 May 24;119(21):e2200413119. doi: 10.1073/pnas.2200413119. Epub 2022 May 16.
Proc Natl Acad Sci U S A. 2022.
PMID: 35576468
Free PMC article.
Clinical features and prognostic factors in Covid-19: A prospective cohort study.
de Bruin S, Bos LD, van Roon MA, Tuip-de Boer AM, Schuurman AR, Koel-Simmelinck MJA, Bogaard HJ, Tuinman PR, van Agtmael MA, Hamann J, Teunissen CE, Wiersinga WJ, Koos Zwinderman AH, Brouwer MC, van de Beek D, Vlaar APJ; Amsterdam UMC COVID-19 Biobank Investigators.
de Bruin S, et al.
EBioMedicine. 2021 May;67:103378. doi: 10.1016/j.ebiom.2021.103378. Epub 2021 May 14.
EBioMedicine. 2021.
PMID: 34000622
Free PMC article.
Item in Clipboard
Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial.
Lim EHT, Vlaar APJ, Bos LDJ, van Vught LA, Boer AMT, Dujardin RWG, Habel M, Xu Z, Brouwer MC, van de Beek D, de Bruin S; Amsterdam UMC COVID-19 Biobank Investigators.
Lim EHT, et al.
Respir Res. 2022 Dec 24;23(1):375. doi: 10.1186/s12931-022-02278-1.
Respir Res. 2022.
PMID: 36566174
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite